Clinical Trial Update: A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating the safety, tolerability, and immune responses of an investigational monovalent chimpanzee adenoviral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Sudan Virus Disease

Drugs mentioned

• Monovalent chimpanzee adenoviral vectored Sudan Ebolavirus vaccine (Chimpanzee adenovirus vector-based Sudan ebolavirus vaccine)

Snippet

Sponsor: Albert B. Sabin Vaccine Institute | Conditions: Ebola Sudan Virus Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING